MedPath

Effect of Weight Reduction on Immunity

Phase 3
Completed
Conditions
Lymphocytes
Viral Diseases
Immunity
Anti-obesity Agents
Weight Loss
Interventions
Combination Product: weight loss program
Registration Number
NCT03336086
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

This study included two groups of premenopausal healthy obese women. Experimental group underwent a weight loss program involved a low calorie diet plus anti-obesity drugs and moderate physical activity and control group underwent an ad libitum diet. At baseline and after a 10-15% weight loss lymphocyte subgroups were analyzed and compared between two group.

Detailed Description

TCD3 and NKC CD16/56 were decreased significantly. Hence this weight loss program impaired viral immunity

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
29
Inclusion Criteria
  • BMI >=30
  • female
  • healthy
  • no smoking
  • not lactating
  • not pregnant
  • no medication use
Read More
Exclusion Criteria
  • pregnancy
  • any disease
  • any medication use
  • iron and zinc deficiency
  • any supplement use
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
experimentalweight loss programThis group underwent a weight loss program
Primary Outcome Measures
NameTimeMethod
lymphocyte subgroups6 months

TCD3. TCD4. TCD8. BCD19. NKCs CD16/56 (Cells/microliter) by flowcytometry

Secondary Outcome Measures
NameTimeMethod
Systolic blood pressure6 months

(mmHg) by manometer

diastolic blood pressure6 months

(mmHg) by manometer

Fat Free Mass6 months

(Kg) by Bioelectric impedance analyser

Waist circumference6 months

(cm) by meter tape

Weight6 months

(Kg) by Bioelectric impedance analyser

Fat Mass6 months

(Kg) by Bioelectric impedance analyser

Body Mass Index6 months

(Kg/m\^2) by equation

Trunk Fat6 months

(Kg) by Bioelectric impedance analyser

Biomarkers6 months

ZN, Iron (microgram/deciliter) by biochemical assessment

© Copyright 2025. All Rights Reserved by MedPath